Resmed (RSMDF) Share-based Compensation Growth (5y) (2014 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Share-based Compensation Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.44% |
| Mar 31, 2026 | 11.44% |
| Dec 31, 2025 | 13.49% |
| Sep 30, 2025 | 5.66% |
| Jun 30, 2025 | 8.93% |
| Mar 31, 2025 | 11.32% |
| Dec 31, 2024 | 10.00% |
| Sep 30, 2024 | 8.74% |
| Jun 30, 2024 | 8.17% |
| Mar 31, 2024 | 9.77% |
| Dec 31, 2023 | 9.61% |
| Sep 30, 2023 | 8.21% |
| Jun 30, 2023 | 9.81% |
| Mar 31, 2023 | 8.44% |
| Dec 31, 2022 | 6.54% |
| Sep 30, 2022 | 7.19% |
| Jun 30, 2022 | 2.16% |
| Mar 31, 2022 | -51.24% |
| Dec 31, 2021 | -29.10% |
| Sep 30, 2021 | 7.51% |